Tyrosine Kinase


Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
-
A8199 PD153035 hydrochloride1 CitationTarget: EGFRSummary: Potent EGFR inhibitor -
A3009 Sorafenib11 CitationTarget: Raf|VEGFRSummary: Raf kinases and tyrosine kinases inhibitor -
A3014 BGJ3981 CitationTarget: FGFRSummary: FGFR inhibitor ,potent and selective -
A3017 Dasatinib (BMS-354825)14 CitationSummary: Src and Bcr-Abl inhibitor -
A4092 CUDC-1011 CitationTarget: Histone Deacetylases (HDACs)|EGFR|ErbBSummary: Multitargeted HDAC inhibitor -
A4139 AG-4903 CitationTarget: EGFR|JAKSummary: JAK2/EGFR inhibitor -
A4145 TG101209Summary: JAK2/3 inhibitor -
A4116 Danusertib (PHA-739358)2 CitationTarget: Aurora KinasesSummary: Pan-aurora kinase inhibitor -
A4123 KW 2449Target: Aurora Kinases|FLT3|Bcr-AblSummary: Multikinase inhibitor -
A4237 Amuvatinib (MP-470, HPK 56)Summary: Tyrosine kinase inhibitor

